Horacio Cárdenas

Northwestern University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

29h-index3.3kcitations212works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(79), RNA modifications and cancer(31), Reproductive Physiology in Livestock(27), Ovarian cancer diagnosis and treatment(19), Genetic and phenotypic traits in livestock(19)

Publications212 total

Supplementary Data from N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase
2025Open Access
Metabolic Dependency on <i>De Novo</i> Pyrimidine Synthesis Is a Targetable Vulnerability in Platinum-Resistant Ovarian Cancer
Cancer Research·2025· 2 cited
Effectiveness of Immediate Pharmacological Versus Electrical Cardioversion on Hemodynamic Stability and Rhythm Restoration in Patients With Refractory Atrial Fibrillation: A Systematic Review
Cureus·2025Open Access
Abstract 3073: Metabolic dependency on de novo pyrimidine synthesis in platinum resistant ovarian cancer
Cancer Research·2025
Abstract 4101: Blood based biomarkers of DNA methylation associated with platinum resistance in high grade serous ovarian cancer
Cancer Research·2025
Tissue transglutaminase as a new immunomodulatory target in ovarian cancer tumor microenvironment
South East European Journal of Immunology·2025· 1 citedOpen Access
Complement activation at the interface between adipocytes and cancer cells drives tumor progression
JCI Insight·2025· 3 citedOpen Access
Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors
Journal of Drugs in Dermatology·2025
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer
UNC Libraries·2024Open Access
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer
npj Genomic Medicine·2024· 6 citedOpen Access
Abstract 443: Unsaturated fatty acids promote cell cycle progression and proliferation of platinum resistant ovarian cancer cells
Cancer Research·2024
Abstract 7047: Comparative analysis of transcriptomic and immunological profiles in treatment-naïve black and non-Hispanic White women with high-grade serous ovarian cancer
Cancer Research·2024
Supplementary Material and Methods S1 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
2024Open Access
Supplementary Table S2 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
2024Open Access
Supplementary Table S1 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
2024Open Access
Supplementary Figure S4 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
2024Open Access
Supplementary Table S6 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
2024Open Access
Supplementary Table S2 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
2024Open Access
Supplementary Figure S3 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
2024Open Access
Supplementary Table S9 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
2024Open Access
page 1 of 11Next →

Frequent Co-authors

Daniela Matei(20), W. F. Pope(11), Kenneth P. Nephew(10), Yinu Wang(9), Guangyuan Zhao(8), Hao Huang(8), Yunlong Liu(6), Ji‐Xin Cheng(5), Salvatore Condello(5), Yuying Tan(4), Edward J. Tanner(4), Ramana V. Davuluri(4), Mónica Imarai(4), Junjie Li(3), Yanrong Ji(3), Robert E. Emerson(3), Fang Fang(3), Matthew W. Segar(3), Edyta Vieth(3), Guanglong Jiang(3)